Significant progress is being made toward diagnosis, evaluation and management of sensori-motor dysfunction, gut microbiota, gut-brain axis, nutrition, eosinophilic esophagitis. Read the most recent news here.
Webinar "Speed date with experts"
The European Society of Neurogastroenterology and Motility and the Turkish Society of Gastroenterology are starting a new Webinar Series entitled “Speed date with experts”. These monthly webinars will cover the latest achievements in our field from globally known experts in just 60 minutes! Join us for the next speed date "Gastroesophageal Reflux Disease" with Daniel Sifrim on Dec, 5, 2022, 7pm https://bit.ly/3MlsG3q
Webinar on C. difficile infection (CDI)
In a series of 7 webinar this programme develops a full picture of the C. difficile infection (CDI) reaching from the importance of a healthy gut microbiota, to its detection and testing methods to current and future therapeutic approaches. Join us for our next webinar "Prevention of recurrence and re-infections" on Oct 12, 4pm (CEST). Registration is free of charge https://bit.ly/3RkD2RK
Abstract submission opens on February 1st, 2023
NeuroGASTRO 2023 is not so far away! Abstract submission will open on February 1st, 2023. Be part of our great programme and meet outstanding speakers. Learn more about our latest abstract topics on the meeting website www.neurogastro2023.org. We are looking forward to receiving many submissions!
Little brain big brain Extraordinary meeting 2022
Graphic Abstract: Association Between Psychosocial Disorders and Gastroesophageal Reflux Disease
The FunDysGWAS ESNM Project
The aim of this project is to create an European based database to investigate the role of different genetic factors that might be linked to functional dyspepsia (FD) symptoms. At present, the project group has collected samples 196 of FD patients and 190 samples of healthy controls. The project ist looking for new centers in Europe that would like to help and are eager to recruit 50 patients or more diagnosed with functional dyspepsia as described by the Rome IV criteria and if possible 50 healthy controls during the next year.
DISCOvERIE: Better diagnose, prevention and treatment for IBS patients